Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report
Lung Cancer
.
1994 Nov:11 Suppl 3:S11-3.
doi: 10.1016/0169-5002(94)91859-7.
Authors
M R Green
,
J D Cox
,
A Ardizzoni
,
R Arriagada
,
G Bureau
,
S Darwish
,
G Deneffe
,
M Fukuoka
,
D Joseph
,
R Komaki
, et al.
PMID:
7704502
DOI:
10.1016/0169-5002(94)91859-7
No abstract available
Publication types
Consensus Development Conference
Review
MeSH terms
Carcinoma, Non-Small-Cell Lung / therapy*
Clinical Trials as Topic
Combined Modality Therapy
Humans
Lung Neoplasms / therapy*
Neoplasm Staging